-

New Advisory Brief and Podcast Reveal What Life Sciences Companies Need to Know to Be Prepared For 2023

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know To Be Prepared for 2023” and its podcast episode “What Leaders In Life Sciences Need To Know To Be Prepared for 2023” based on highlights presented at the TGaS Advisors’ 2022 Fall Client Summit. The TGaS 2022 Fall Client Summit was held in October at the W Hotel Philadelphia with nearly 200 attendees from 100 life sciences companies, the largest in-person Summit to date.

As the commercial model for life sciences companies continues to evolve, executives need to optimize their organizational structure, talent and capabilities to excel in the future. According to the new brief and podcast, omnichannel marketing, data management and advanced analytics are critical areas for capability transformation. To help maximize customer engagement, new ways of working are emerging, including the evolution of matrix-based field teams. Retaining and motivating talent in a changing work environment will remain a challenge in the coming year. Organizations should also consider how to define and interpret their key performance metrics to better align with the transforming commercial model.

“With the rapid evolution of the commercial model, organizations need to develop new capabilities and transform their existing capabilities to compete in today’s complicated biopharma commercial landscape,” said Gary McWalters, President of TGaS Advisors, a division of Trinity Life Sciences. “Capabilities such as next best action and a solid technology and data strategy are not only foundational but also the cost of entry.”

To download the brief, please visit TrinityLifeSciences.com or click here. To listen to the podcast, click here.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom